{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "interpro:IPR003966",
      "entity_text" : "thrombin",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:10077130",
      "entity_text" : "vorapaxar",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "XREF_BIBR XREF_BIBR Furthermore, in this study samples were taken from stable CAD patients, while the beneficial effect of vorapaxar in reducing thrombin generation might become more pronounced under conditions of acute plaque rupture, when levels of thrombin rise explosively.",
  "reading_complete" : "2020-08-03T12:40:21Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T12:39:34Z",
  "trigger" : "reducing",
  "evidence" : [ "vorapaxar in reducing thrombin" ],
  "pmc_id" : "6697509",
  "score" : 0
}